Key result
Mild PVR after TAVR is linked to ~64% higher mortality risk versus none-to-trace PVR.
Why the study?
The study was conducted to evaluate the incidence and prognostic impact of paravalvular regurgitation on outcomes after TAVR and SAVR for aortic stenosis.
Does mild or moderate-to-severe paravalvular regurgitation reduce 4-year survival in patients undergoing TAVR or SAVR for aortic stenosis?
Population
6463 consecutive patients undergoing TAVR or SAVR with a bioprosthesis for aortic stenosis
Comparison
Mild or moderate-to-severe PVR vs none-to-trace PVR at discharge
Design
Nationwide registry multicentre cohort study
Follow-up
4-year
Authors
Loading...
Mild PVR after TAVR may worsen survival; leaves open whether minimizing it improves outcomes in randomized data.
Cohort (n=6,463)
Yes
Does mild or moderate-to-severe paravalvular regurgitation reduce 4-year survival in patients undergoing TAVR or SAVR for aortic stenosis?
Effect estimate: adjusted HR 1.64 (95% CI 1.35-1.99)
Absolute Event Rate: 54.2% vs 69%
Mild and moderate-to-severe paravalvular regurgitation after TAVR are independent predictors of worse mid-term survival, emphasizing the importance of minimizing PVR.
Laakso et al. (2020) conducted a cohort in aortic stenosis (n=6,463). Paravalvular regurgitation (PVR) vs. None-to-trace PVR was evaluated on 4-year survival after TAVR (mild PVR vs none-to-trace) (adjusted HR 1.64, 95% CI 1.35-1.99). Mild paravalvular regurgitation after TAVR was associated with worse 4-year survival compared to none-to-trace PVR (54.2% vs 69.0%; adjusted HR 1.64, 95% CI 1.35-1.99).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: